Plasma and myocardial digoxin concentrations in patients on oral therapy.
作者信息
Binnion P F, Morgan L M, Stevenson H M, Fletcher E
出版信息
Br Heart J. 1969 Sep;31(5):636-40. doi: 10.1136/hrt.31.5.636.
Abstract
摘要
相似文献
1
Plasma and myocardial digoxin concentrations in patients on oral therapy.接受口服治疗患者的血浆和心肌地高辛浓度
Br Heart J. 1969 Sep;31(5):636-40. doi: 10.1136/hrt.31.5.636.
2
New ways with digoxin.地高辛的新应用
Lancet. 1970 Mar 28;1(7648):678. doi: 10.1016/s0140-6736(70)90915-3.
3
[Digoxin concentration in the myocardium and plasma in patients with long-term digitalis therapy].
Verh Dtsch Ges Inn Med. 1978(84):752-4.
4
Determination of myocardial and serum digoxin concentrations in children by specific and nonspecific assay methods.
Clin Pharmacol Ther. 1983 May;33(5):577-84. doi: 10.1038/clpt.1983.78.
5
Physiological distribution of digoxin in human heart.地高辛在人心脏中的生理分布。
Br Med J. 1974 Dec 28;4(5947):733-6. doi: 10.1136/bmj.4.5947.733.
6
Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.人体右心房心肌、骨骼肌和血清中的地高辛浓度：心房节律的影响。
Eur J Clin Pharmacol. 1980 Apr;17(4):243-50. doi: 10.1007/BF00625797.
7
Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.埃佛勒斯峰医学研究：血浆中地高辛的测定及其在诊断地高辛中毒中的应用。
Br Med J. 1969 Feb 1;1(5639):286-9. doi: 10.1136/bmj.1.5639.286.
8
[Correlation of the myocardial concentration with the blood concentration of digoxin].
Zhonghua Yi Xue Za Zhi. 1987 Jun;67(6):337-9, 22.
9
Factors influencing the inhibition by digoxin of 86 Rubidium uptake into human red cells.影响地高辛对铷86摄入人红细胞抑制作用的因素。
Med Lab Sci. 1979;36(4):339-52.
10
The plasma digoxin concentration, red cell rubidium 86 uptake and control of ventricular rate in patients being digitalized for artrial fibrilation.
Clin Sci. 1972 Jan;42(1):3P. doi: 10.1042/cs042003pa.
引用本文的文献
1
Clinical pharmacokinetics of digoxin 1980.地高辛的临床药代动力学 1980 年
Clin Pharmacokinet. 1980 Mar-Apr;5(2):137-49. doi: 10.2165/00003088-198005020-00002.
2
Measurement of plasma digoxin concentration by radioimmunoassay.用放射免疫分析法测定血浆地高辛浓度。
Br Med J. 1970 Aug 22;3(5720):427-8. doi: 10.1136/bmj.3.5720.427.
3
Drug intoxication in renal failure.肾衰竭中的药物中毒
Br Med J. 1970 May 16;2(5706):376-7.
4
Clinical use of a bio-assay of serum digitoxin activity.血清洋地黄毒苷活性生物测定法的临床应用。
Eur J Clin Pharmacol. 1971 Sep;3(4):236-42. doi: 10.1007/BF00565013.
5
Plasma digoxin concentration--its relation to digoxin dosage and clinical effects in patients with atrial fibrillation.血浆地高辛浓度——心房颤动患者中其与地高辛剂量及临床疗效的关系
Br Heart J. 1972 Apr;34(4):383-91. doi: 10.1136/hrt.34.4.383.
6
Human plasma digoxin levels.人体血浆地高辛水平。
Ir J Med Sci. 1974 Jan;143(1):30-6. doi: 10.1007/BF03004738.
7
[The inhibitory effect of cardiac glycosides on 86 Rb-uptake of erythrocytes. I. Studies on the determination of cymarin (k-strophantin-a) and digitoxin].[强心苷对红细胞摄取⁸⁶Rb的抑制作用。I. 洋地黄毒苷（k-毒毛旋花子苷-a）和地高辛的测定研究]
Eur J Clin Pharmacol. 1972 Mar;4(2):92-8. doi: 10.1007/BF00562503.
8
A modern view of pharmacokinetics.药物动力学的现代观点。
J Pharmacokinet Biopharm. 1973 Oct;1(5):363-401. doi: 10.1007/BF01059664.
9
Beta-methyl-digoxin. VII. Tissue distribution, positive inotropic and central action in cats in comparison with other digitalis glycosides.β-甲基地高辛。VII. 与其他洋地黄苷相比，猫体内的组织分布、正性肌力作用及中枢作用
Naunyn Schmiedebergs Arch Pharmacol. 1974;286(2):195-210. doi: 10.1007/BF00501612.
10
[Determination of digoxin and digitoxin in the blood and their clinical significance].[血液中地高辛和洋地黄毒苷的测定及其临床意义]
Klin Wochenschr. 1973 Jan 15;51(2):57-62. doi: 10.1007/BF01467756.
本文引用的文献
1
A METHOD FOR MEASURING PLASMA LEVELS OF DIGITALIS GLYCOSIDES.一种测定洋地黄苷血浆水平的方法。
Circulation. 1965 Feb;31:228-33. doi: 10.1161/01.cir.31.2.228.
2
DISTRIBUTION IN PLASMA, UPTAKE BY THE HEART AND EXCRETION OF OUABAIN-H3 IN HUMAN SUBJECTS.哇巴因 - H3在人体血浆中的分布、心脏摄取及排泄情况
J Pharmacol Exp Ther. 1964 Sep;145:351-6.
3
Tritiated digoxin studies in human subjects.人体受试者中的氚标记地高辛研究。
Arch Intern Med. 1961 Oct;108:531-9. doi: 10.1001/archinte.1961.03620100023004.
4
Double isotope dilution derivative assay of digitoxin in plasma, urine, and stool of patients maintained on the drug.接受地高辛治疗的患者血浆、尿液和粪便中地高辛的双同位素稀释衍生测定法。
J Clin Invest. 1966 May;45(5):782-95. doi: 10.1172/JCI105393.
5
An improved method for measuring plasma and tissue concentrations of digitalis glycosides.一种测量洋地黄苷血浆和组织浓度的改进方法。
J Lab Clin Med. 1966 Jun;67(6):1048-52.
6
Tissue concentration and turnover of tritiated digoxin in dogs.犬体内氚标记地高辛的组织浓度与周转率
Am J Cardiol. 1966 Jan;17(1):47-52. doi: 10.1016/0002-9149(66)90259-1.
7
Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.埃佛勒斯峰医学研究：血浆中地高辛的测定及其在诊断地高辛中毒中的应用。
Br Med J. 1969 Feb 1;1(5639):286-9. doi: 10.1136/bmj.1.5639.286.
8
The measurement of digitoxin in human serum by radioimmunoassay.采用放射免疫分析法测定人血清中地高辛的含量。
J Clin Invest. 1968 May;47(5):1035-42. doi: 10.1172/JCI105793.
9
A comparison of the accumulation and release of 3H-ouabain and 3H-digitoxin by guinea-pig heart muscle.豚鼠心肌对3H-哇巴因和3H-地高辛的摄取与释放比较。
Br J Pharmacol Chemother. 1968 Mar;32(3):598-608. doi: 10.1111/j.1476-5381.1968.tb00460.x.
10
Digoxin-specific antibodies.地高辛特异性抗体。
Proc Natl Acad Sci U S A. 1967 Jan;57(1):71-8. doi: 10.1073/pnas.57.1.71.
Zotero 插件